(Pro3)-Gastric Inhibitory Polypeptide (human) trifluoroacetate salt
Modify Date: 2024-01-03 10:50:45
(Pro3)-Gastric Inhibitory Polypeptide (human) trifluoroacetate salt structure
|
Common Name | (Pro3)-Gastric Inhibitory Polypeptide (human) trifluoroacetate salt | ||
|---|---|---|---|---|
| CAS Number | 299898-52-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C226H338N60O64S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (Pro3)-Gastric Inhibitory Polypeptide (human) trifluoroacetate salt(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human has high binding affinity for human GIPR with Ki/ Kd values of 0.90 nM. (Pro3) GIP, human can be used for the research of obesity-related diabetes[1][2]. |
| Name | (Pro3)-Gastric Inhibitory Polypeptide (human) trifluoroacetate salt |
|---|
| Description | (Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist. (Pro3) GIP, human has high binding affinity for human GIPR with Ki/ Kd values of 0.90 nM. (Pro3) GIP, human can be used for the research of obesity-related diabetes[1][2]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 0.026 nM (hGIPR)[2] Ki/Kd: 0.90 nM (hGIPR); 1.1 nM (Rat GIPR); 0.72 nM (Mouse GIPR)[2] |
| In Vitro | (Pro3) GIP, human induces cAMP accumulation with an EC50 value of 0.026 nM[2]. (Pro3) GIP, human has high binding affinity for human GIPR, Rat GIPR and Mouse GIPR with Ki/ Kd values of 0.90 nM, 1.1 nM and 0.72 nM, respectively[2]. |
| In Vivo | (Pro3) GIP, human has comparatively weak partial agonist effect in rodent models[2]. |
| Molecular Formula | C226H338N60O64S |
|---|